A sustained-release microsphere of sodium carboxymethyl cellulose and its preparation method
By using a composite network composed of a modified porous starch-chitosan composite sustained-release regulator and sodium carboxymethyl cellulose, sodium alginate, etc., the problems of rapid initial release, poor stability and release regulation of sodium carboxymethyl cellulose sustained-release microspheres were solved, and continuous release and stability were achieved under different pH conditions.
Patent Information
- Application Number
- CN202611263024.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-19
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2046-08-19
AI Technical Summary
Existing sodium carboxymethyl cellulose sustained-release microspheres have problems such as rapid initial drug release, insufficient microsphere structural stability, poor drug loading and immobilization, and difficulty in continuously controlling the release process.
A modified porous starch-chitosan composite sustained-release regulator is used. This regulator consists of a core-shell-complex network composed of a porous starch adsorption core, a chitosan cationic hydration composite layer, a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, and a calcium-polyanionic cross-linked outer layer. It is combined with sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methylcellulose to form a composite hydrophilic gel-ionic cross-linked network, thereby regulating drug release.
This technology reduces rapid swelling and burst release of drugs in the gastric fluid environment and achieves sustained release in the intestinal fluid environment, improving the structural stability and release cycle of microspheres and ensuring stable drug release under different pH conditions.
Smart Images

Figure CN122786288B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical formulation technology, specifically to a sodium carboxymethyl cellulose sustained-release microsphere and its preparation method. Background Technology
[0002] Sustained-release formulations can prolong the duration of drug action, reduce fluctuations in blood drug concentration, and improve the convenience of administration and medication adherence by regulating the release rate of drugs in the gastrointestinal tract. Microspheres, as a common sustained-release carrier, have the characteristics of large specific surface area, adjustable drug loading, good dispersibility, and easy control of release behavior, and have been widely used in the encapsulation, protection, and controlled release of active pharmaceutical ingredients.
[0003] Sodium carboxymethyl cellulose (CMC) possesses excellent hydrophilicity, film-forming properties, adhesiveness, and biocompatibility, making it suitable as a polymeric framework material in sustained-release formulations. Sodium alginate can form a gel network with calcium ions, and chitosan can form a polyelectrolyte complex structure with anionic polysaccharides or polyvalent anions; both can be used to regulate drug release. However, existing CMC-based sustained-release microspheres still have the following shortcomings: First, a single polymeric framework is prone to rapid water absorption and swelling or surface erosion in the gastric fluid environment, leading to a rapid initial drug release. Second, the adsorption and fixation of some active drug components within the microspheres are insufficient, easily resulting in burst release. Third, there is a lack of synergistic regulation between the internal pore structure, ionic cross-linking structure, and hydrophilic gel structure of the microspheres, making it difficult to simultaneously achieve drug loading stability, low release in the gastric fluid stage, and sustained release in the intestinal fluid stage. Fourth, the network structure stability of conventional porous carriers or single chitosan-coated materials is limited, resulting in insufficient ability to regulate release under different pH conditions.
[0004] Therefore, it is necessary to provide a sustained-release microsphere with sodium carboxymethyl cellulose as the main component and incorporating modified sustained-release regulating components that have drug adsorption and immobilization properties, hydrophilic swelling regulation properties, ion complexation stability and multilayer network blocking effects, in order to solve the problems of obvious burst release, insufficient release period, poor structural stability and low precision of sustained-release regulation of existing sustained-release microspheres. Summary of the Invention
[0005] The purpose of this invention is to address the problems of rapid initial drug release, insufficient microsphere structural stability, poor drug loading and immobilization, and difficulty in continuously controlling the release process in existing technologies, by providing a sodium carboxymethyl cellulose sustained-release microsphere and its preparation method.
[0006] To achieve the above objectives, the technical solution adopted by the present invention is as follows: A sodium carboxymethyl cellulose sustained-release microsphere, wherein the microsphere is prepared from the following raw materials in parts by weight: 100 parts sodium carboxymethyl cellulose, 15-45 parts active pharmaceutical ingredient, 15-35 parts sodium alginate, 6-18 parts hydroxypropyl methylcellulose, 8-22 parts modified porous starch-chitosan composite sustained-release regulator, 3-10 parts microcrystalline cellulose, 1-5 parts glycerol, 8-20 parts calcium chloride, 2-8 parts sodium tripolyphosphate, 0.5-3 parts glacial acetic acid, 0.5-3 parts sodium bicarbonate, 40-100 parts ethanol, and 300-650 parts purified water.
[0007] By adopting the above technical solution, the modified porous starch-chitosan composite sustained-release regulator is a core-shell-complex network type composite sustained-release regulator composed of a porous starch adsorption core, a chitosan cationic hydration composite layer, a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, and a calcium-polyanion crosslinked outer layer.
[0008] Furthermore, by adopting the above technical solution, the modified porous starch-chitosan composite sustained-release regulator is prepared from the following raw materials in parts by weight: 100 parts porous starch, 25-55 parts chitosan, 6-18 parts sodium citrate, 4-12 parts sodium phytate, 5-16 parts calcium lactate, 2-8 parts hydroxypropyl methylcellulose, 1-5 parts tannic acid, 1-6 parts sodium alginate, 1-6 parts glacial acetic acid, 0.5-3 parts sodium bicarbonate, 120-240 parts ethanol, and 2500-4500 parts purified water.
[0009] By adopting the above technical solution, the preparation method of the modified porous starch-chitosan composite sustained-release regulator further includes the following steps: S1. Porous starch is added to an ethanol-water solution composed of ethanol and purified water, wherein the mass ratio of ethanol to purified water in the ethanol-water solution is 1:2-1:5, and the solid-liquid ratio of porous starch to ethanol-water solution is controlled to be 1:8-1:15. The mixture is dispersed at 25-35℃ and 300-600r / min for 20-40min. Sodium citrate and sodium bicarbonate are added to adjust the pH of the system to 6.0-7.2. The mixture is stirred for another 40-90min and then filtered to obtain sodium citrate pre-activated porous starch.
[0010] S2. Chitosan is added to purified water containing glacial acetic acid, wherein the mass concentration of glacial acetic acid in the purified water is 0.5-2.0%, and dissolved at 35-45℃ and 500-800r / min for 1-3h. Tannic acid and hydroxypropyl methylcellulose are added, and the pH is adjusted to 4.5-5.5 to obtain a chitosan cationic coating solution.
[0011] S3. Add the sodium citrate pre-activated porous starch obtained in step S1 to the chitosan cationic coating solution obtained in step S2, controlling the solid-liquid ratio of the sodium citrate pre-activated porous starch to the chitosan cationic coating solution to be 1:10-1:18. Stir for 1.5-4 hours at 30-45℃ and 400-700 r / min to form a hydrated cationic composite layer of chitosan on the surface of the porous starch and on the pore walls. The citrate ions are distributed in the pore walls of the porous starch in an adsorbed state and an ion-associated state. The phytate complex is formed in the chitosan composite layer, and carboxylate sites that can interact with subsequent polyvalent anions and calcium ions are retained. Then, a sodium phytate aqueous solution with a mass concentration of 1-5% is added dropwise at a rate of 0.5-2.0 mL / min. After the addition is completed, the pH is adjusted to 5.0-6.2, and the reaction continues for 1-3 h. This allows the phytate to form a polyelectrolyte complex with the protonated chitosan, and together with the citrate, forms a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, thus obtaining the sodium phytate complex-coated complex.
[0012] S4. Dissolve sodium alginate in purified water to prepare a sodium alginate aqueous solution with a mass concentration of 0.3-1.5%. Add the sodium phytate complex obtained in step S3 to the sodium alginate aqueous solution and disperse it, so that sodium alginate is adsorbed on the surface and near-surface area of the complex. Dissolve calcium lactate in purified water to prepare a calcium lactate aqueous solution, and add it dropwise to the sodium alginate dispersion system containing the sodium phytate complex at a dropping rate of 0.5-2.0 mL / min. Control the solid-liquid ratio of the sodium phytate complex to the sodium alginate dispersion system to be 1:8-1:16. Perform a cross-linking reaction at 25-40℃ and 300-600 r / min for 2-5 h, so that calcium ions coordinate and cross-link with sodium alginate, phytate and citrate on the surface and near-surface of the complex to form a calcium-polyanionic cross-linked outer layer.
[0013] S5. Filter the product obtained in step S4, wash it with purified water until the pH of the filtrate is 6.2-7.0, then wash it 1-3 times with an ethanol aqueous solution with a volume fraction of 50-75%, and vacuum dry it at 35-50℃ for 8-18 hours with a vacuum degree of -0.06MPa to -0.09MPa. After drying, use low-shear grinding to gently depolymerize and pass it through a 100-300 mesh sieve to obtain the modified porous starch-chitosan composite sustained-release regulator.
[0014] By adopting the above technical solution, the degree of substitution of the sodium carboxymethyl cellulose is 0.65-0.95, and the viscosity of the 2% mass concentration aqueous solution at 25°C is 300-2000 mPa·s.
[0015] By adopting the above technical solution, the viscosity of the 1% mass concentration aqueous solution of sodium alginate at 25°C is further 10-40 cps.
[0016] By adopting the above technical solution, the viscosity of the 2% mass concentration aqueous solution of hydroxypropyl methylcellulose is further 2600-5800 mPa·s.
[0017] By adopting the above technical solution, the average particle size of the porous starch is further 10-80 μm.
[0018] By adopting the above technical solution, the degree of deacetylation of the chitosan is further ≥75%.
[0019] By adopting the above technical solution, the modified porous starch-chitosan composite sustained-release regulator exhibits a mass swelling ratio of 4.0-12.0 times in phosphate buffer solution at pH 6.8 for 6 hours.
[0020] Furthermore, by adopting the above technical solution, the active pharmaceutical ingredient is one of ibuprofen, theophylline, metformin, aspirin, diclofenac sodium, berberine hydrochloride, and acetaminophen.
[0021] By adopting the above technical solution, the cumulative release rate of the sodium carboxymethyl cellulose sustained-release microspheres is 5-30% in hydrochloric acid solution at pH 1.2 for 2 hours, 55-90% in phosphate buffer solution at pH 6.8 for 12 hours, and 80-98% in phosphate buffer solution at pH 6.8 for 24 hours.
[0022] This invention also provides a method for preparing sodium carboxymethyl cellulose sustained-release microspheres, characterized by comprising the following steps: A1. Add sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methyl cellulose to purified water and stir for 1-3 hours at 25-45℃ and 500-1000 r / min to obtain a composite polymer matrix solution.
[0023] A2. The active pharmaceutical ingredient is premixed with the modified porous starch-chitosan composite sustained-release regulator and then added to the composite polymer matrix liquid obtained in step A1. The mixture is dispersed at 25-40℃ and 600-1200r / min for 30-90min to ensure that the active pharmaceutical ingredient is uniformly dispersed in the composite polymer matrix liquid. Partial immobilization is achieved through the adsorption of the porous starch channels, the chitosan cationic hydration composite layer, and the polysaccharide network. Subsequently, microcrystalline cellulose and glycerol are added and dispersion is continued to obtain the drug-loaded dispersion.
[0024] A3. Add glacial acetic acid to the drug-loaded dispersion obtained in step A2, adjust the pH to 5.0-6.5, then add sodium bicarbonate, and stir for 10-40 minutes at 300-800 r / min to obtain the pre-spherical solution.
[0025] A4. Dissolve calcium chloride and sodium tripolyphosphate in a mixture of purified water and ethanol to prepare a composite ion crosslinking solution, wherein the mass concentration of calcium chloride in the composite ion crosslinking solution is 1.5-6.0% and the mass concentration of sodium tripolyphosphate is 0.5-3.0%.
[0026] A5. After allowing the pre-spherical liquid obtained in step A3 to stand for degassing for 10-30 minutes, use a dropping needle or nozzle with an inner diameter of 0.45-0.80 mm to drop it into the composite ion crosslinking liquid obtained in step A4 at a dropping rate of 0.5-3.0 mL / min and a dropping height of 5-10 cm. During the dropping process, control the composite ion crosslinking liquid to be stirred at 200-500 r / min. Cure and crosslink at 20-35℃ for 1-6 h. Filter and collect the spherical product, wash it with purified water until the pH of the washing solution is 6.2-7.2, and dry it at 35-55℃ for 8-24 h. After drying, sieve to remove particles with a particle size greater than 1.50 mm and less than 0.20 mm to obtain sodium carboxymethyl cellulose sustained-release microspheres with an average particle size of 0.20-1.50 mm.
[0027] By adopting the above technical solution, the mass ratio of purified water and ethanol in step A4 is further 3:1-8:1.
[0028] By adopting the above technical solution, further, when the pre-forming sphere liquid is dripped into the composite ion crosslinking liquid in step A5, the volume ratio of the pre-forming sphere liquid to the composite ion crosslinking liquid is 1:5-1:15.
[0029] The present invention relates to the application of sodium carboxymethyl cellulose sustained-release microspheres in the preparation of oral sustained-release drug formulations.
[0030] The present invention relates to the application of sodium carboxymethyl cellulose sustained-release microspheres in the manufacture of biopharmaceuticals.
[0031] The modified porous starch-chitosan composite sustained-release regulator of this invention is a core-shell-complex network type composite sustained-release regulator composed of a porous starch adsorption core, a chitosan cationic hydration composite layer, a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, and a calcium-polyanion crosslinked outer layer. In sodium carboxymethyl cellulose sustained-release microspheres, it does not merely exist as a common filler carrier, but rather regulates the fixation, swelling, and diffusion processes of the active pharmaceutical ingredient through accessible pore adsorption, polymer matrix embedding, polyelectrolyte complexation, and ionic crosslinking. Specifically, the porous starch adsorption core relies on its accessible pores and large specific surface area to adsorb and spatially confine some of the active pharmaceutical ingredient, while the active pharmaceutical ingredient that does not enter the pores is dispersed. Within a gel matrix composed of sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methyl cellulose, a chitosan cationic hydration composite layer serves as a permeable interfacial layer, not a completely sealed outer shell. This layer can form hydrogen bonds, electrostatic adsorption, and polyelectrolyte complexes with sodium carboxymethyl cellulose, sodium alginate, and the active pharmaceutical ingredient, thereby improving the drug loading and immobilization within the microspheres. A sodium citrate-assisted sodium phytate-chitosan complex intermediate layer further enhances the multivalent anion complexation and blocking effect, preventing water ingress and drug diffusion from proceeding through simple, rapid channels. The calcium-polyanion crosslinked outer layer forms a stable ionic crosslinking network with sodium alginate, phytate, and citrate, improving the swelling resistance and structural integrity of the microspheres in the release medium. Therefore, the drug release process is not a simple reverse process of the dispersion and adsorption process in the preparation stage. Instead, it involves hydration, drug dissolution, pore desorption, and diffusion of the gel layer and ion cross-linking network in the dried and solidified microspheres. This allows the sodium carboxymethyl cellulose sustained-release microspheres to inhibit initial rapid swelling and drug burst release in hydrochloric acid solution at pH 1.2, while in phosphate buffer solution at pH 6.8, they can achieve continuous release through gradual hydration, relaxation, and diffusion along with the composite network. This reduces the rapid release in the gastric juice stage while maintaining a high level of subsequent release sufficiency in the intestinal juice stage, demonstrating a good balance between drug loading stability, low burst release, and long-term release.
[0032] The components of this invention synergistically address the problems of rapid initial drug release, insufficient microsphere structural stability, poor drug loading and fixation, and difficulty in continuously controlling the release process through the construction of a main hydrophilic framework, cross-linking of composite ions into spheres, multi-level sustained-release regulation, and auxiliary molding stabilization. Specifically, sodium carboxymethyl cellulose serves as the main sustained-release framework, forming a continuous polymer network based on its hydrophilicity, film-forming properties, and adhesiveness. Sodium alginate forms a calcium ion cross-linked gel structure under the action of calcium chloride. Hydroxypropyl methylcellulose further regulates the system's viscosity, hydration swelling rate, and gel layer integrity. Sodium tripolyphosphate interacts with the cationic components in the system to form a composite hydrophilic gel-ion cross-linked network within the microspheres. The porous starch adsorption core in the modified porous starch-chitosan composite sustained-release regulator adsorbs and fixes some of the active drug components through pores, while the chitosan cation... The ion-hydrated composite layer enhances the interfacial adsorption and polyelectrolyte complexation between sodium carboxymethyl cellulose, sodium alginate, and the active pharmaceutical ingredient. The sodium citrate-assisted sodium phytate-chitosan complex intermediate layer and the calcium-polyanion crosslinked outer layer further improve the network density and swelling resistance, transforming drug release from a single gel diffusion to a process jointly controlled by pore adsorption, cation complexation, complexation retardation, and ion crosslinking. Microcrystalline cellulose improves the internal support and dispersion uniformity of the microspheres, glycerol reduces the risk of drying shrinkage and brittleness, glacial acetic acid is used to moderately lower the system pH during the pre-sphere formation stage and promote the amino protonation of chitosan, and sodium bicarbonate is used to neutralize free acid and adjust the system pH to a suitable range for sphere formation. These two are pH-adjusting components added sequentially rather than synergistic components that coexist in the system for a long time. Ethanol and purified water jointly regulate the dispersion, solidification, and drying behavior of the system. Through the combination of the above components, the microspheres can reduce rapid water absorption and swelling and drug extravasation in hydrochloric acid solution at pH 1.2, and achieve sustained release through gradual hydration, relaxation, and diffusion along with the composite network in phosphate buffer solution at pH 6.8. This balances low burst release in gastric juice, sufficient release in intestinal juice, drug loading stability, and microsphere integrity. Compared with existing technologies, the advantages of this invention are: 1. The sodium carboxymethyl cellulose sustained-release microspheres use sodium carboxymethyl cellulose as the main sustained-release framework, combined with sodium alginate, hydroxypropyl methylcellulose, calcium chloride and sodium tripolyphosphate to form a composite hydrophilic gel-ion cross-linking network, which enables the microspheres to have good structural stability and sustained release capability in the release environment, thereby reducing the initial burst release of the active drug ingredient and prolonging the release period.
[0033] 2. This sodium carboxymethyl cellulose sustained-release microsphere incorporates a modified porous starch-chitosan composite sustained-release regulator. The porous starch adsorption core is used to adsorb and fix some of the active pharmaceutical ingredients through the pores. The chitosan cationic hydration composite layer enhances interfacial adsorption and ion recombination. The sodium citrate-assisted sodium phytate-chitosan complex intermediate layer and calcium-polyanion crosslinked outer layer improve the network density and swelling resistance. This transforms drug release from a single gel diffusion to a process jointly controlled by pore adsorption, polyelectrolyte recombination, complexation inhibition, and ion crosslinking, resulting in more stable sustained-release regulation.
[0034] 3. In the acidic environment of gastric juice, the sodium carboxymethyl cellulose sustained-release microspheres can reduce rapid swelling and drug extravasation through their composite network structure. In the near-neutral environment of intestinal juice, they can achieve sustained release by gradually hydrating and swelling with the hydrophilic skeleton. This balances low burst release and sufficient subsequent release, which is beneficial to improving the release stability of sustained-release formulations.
[0035] 4. The preparation method of this sodium carboxymethyl cellulose sustained-release microspheres adopts aqueous phase dispersion, composite ion crosslinking, solidification into spheres and low temperature drying process. The reaction conditions are mild, the parameters are easy to control, the raw materials are widely available, and the microsphere particle size, sphere integrity and drug dispersion uniformity can be guaranteed, which is suitable for industrial scale-up preparation.
[0036] 5. The sodium carboxymethyl cellulose sustained-release microspheres are formulated with microcrystalline cellulose, glycerol, glacial acetic acid, and sodium bicarbonate to assist in the regulation of the system's dispersibility, flexibility, pH state, and sphere formation process. Glacial acetic acid and sodium bicarbonate are added sequentially as pH-adjusting components, which can reduce the risk of microsphere drying shrinkage, rupture, and drug migration, resulting in microspheres with better formulation processing adaptability and application stability. Attached Figure Description
[0037] Figure 1 The infrared spectrum of the modified porous starch-chitosan composite sustained-release regulator prepared in Example 1 of this invention.
[0038] Figure 2 Scanning electron microscope and energy dispersive spectroscopy (EDS) elemental distribution maps of the modified porous starch-chitosan composite sustained-release regulator obtained in Example 1 of this invention. Detailed Implementation
[0039] The technical solution of the present invention will now be clearly and completely described with reference to the accompanying drawings. Obviously, the described embodiments are merely some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0040] Preparation Example 1 Preparation of modified porous starch-chitosan composite sustained-release regulator: 1. Weight of formula: 100 parts porous starch, 35 parts chitosan, 12 parts sodium citrate, 8 parts sodium phytate, 10 parts calcium lactate, 5 parts hydroxypropyl methylcellulose, 3 parts tannic acid, 4 parts sodium alginate, 6 parts glacial acetic acid, 2.5 parts sodium bicarbonate, 180 parts ethanol, and 3500 parts purified water.
[0041] The porous starch has a particle size of 15-25μm and was purchased from Liaoning Lida Biotechnology Co., Ltd. It is a porous starch-slow-release agent.
[0042] The chitosan, with a degree of deacetylation ≥80%, was purchased from THIAI (Shanghai) Chemical Industry Development Co., Ltd.
[0043] The 2% aqueous solution of hydroxypropyl methylcellulose had a viscosity of 5574 mPa·s and was purchased from Shanghai Maclean Biochemical Technology Co., Ltd.
[0044] Sodium alginate, with a 1% aqueous solution having a viscosity of 21 cps, was purchased from Shanghai Maclean Biochemical Technology Co., Ltd.
[0045] 2. Preparation method: S1. Weigh 100 parts of porous starch and add it to an ethanol-water solution composed of 180 parts of ethanol and 720 parts of purified water. The mass ratio of ethanol to purified water is 1:4. Control the solid-liquid ratio of porous starch to ethanol-water solution to be 1:9. Disperse the mixture at 30℃ and 500r / min for 30min. Add 12 parts of sodium citrate and 1.0 part of sodium bicarbonate. Control the pH of the system to be 6.6. Continue stirring for 60min. Filter the mixture to obtain sodium citrate pre-activated porous starch.
[0046] S2. Add 6 parts of glacial acetic acid to 1200 parts of purified water to prepare an acetic acid aqueous solution with a mass concentration of 0.5%; add 35 parts of chitosan to the acetic acid aqueous solution and dissolve it at 40℃ and 650r / min for 2h; add 3 parts of tannic acid and 5 parts of hydroxypropyl methylcellulose, continue stirring for 40min, add 0.8 parts of sodium bicarbonate to adjust the pH to 5.0, and obtain a chitosan cationic coating solution.
[0047] S3. Add the sodium citrate pre-activated porous starch obtained in step S1 to the chitosan cationic coating solution obtained in step S2, controlling the solid-liquid ratio of the sodium citrate pre-activated porous starch to the chitosan cationic coating solution to be 1:12. Stir at 38℃ and 600 r / min for 3 h to form a hydrated cationic composite layer of chitosan on the surface of the porous starch and on the pore walls. The citrate ions are distributed in the pore walls of the porous starch and the chitosan composite layer in an adsorbed and ion-associated state, and retain the ability to interact with subsequent polyvalent anions. The carboxylate sites for interaction with ions and calcium ions: Dissolve 8 parts of sodium phytate in 200 parts of purified water to prepare a 4% sodium phytate aqueous solution, and add it dropwise to the above system at a rate of 1.0 mL / min. After the addition is complete, add 0.7 parts of sodium bicarbonate to adjust the pH to 5.8, and continue the reaction for 2 hours to allow phytate to form a polyelectrolyte complex with protonated chitosan, and together with citrate to form a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, thus obtaining a sodium phytate complex-coated complex.
[0048] S4. Add 4 parts of sodium alginate to 800 parts of purified water and stir for 1.5 h at 35℃ and 500 r / min to prepare an aqueous solution of sodium alginate. Add the sodium phytate complex obtained in step S3 to the aqueous solution of sodium alginate and disperse for 30 min at 32℃ and 450 r / min to allow sodium alginate to adsorb onto the surface and near-surface region of the complex. Separately, dissolve 10 parts of calcium lactate in 500 parts of purified water to prepare an aqueous solution of calcium lactate, and add it dropwise to the above dispersion system at a rate of 1.0 mL / min. During the dropwise addition, maintain stirring at 32℃ and 450 r / min. After the dropwise addition is completed, continue the cross-linking reaction for 3.5 h to allow calcium ions to coordinate and cross-link with sodium alginate, phytate, and citrate on the surface and near-surface of the complex, forming a calcium-polyanionic cross-linked outer layer. After the reaction is completed, remove unbound salts and a small amount of free sediment by filtration and washing.
[0049] S5. The product obtained in step S4 is filtered, washed with purified water until the pH of the filtrate is 6.6, and then washed twice with a 65% ethanol aqueous solution. It is then vacuum dried at 45°C for 12 hours at a vacuum degree of -0.08 MPa. After drying, it is gently depolymerized by low-shear grinding until no visible agglomerates are found, and then passed through a 200-mesh sieve. The powder passing through the sieve is collected to obtain the modified porous starch-chitosan composite sustained-release regulator.
[0050] like Figure 1 As shown, 3400cm -1 A broad and strong OH / NH stretching vibration absorption peak appears nearby, mainly originating from the hydroxyl groups in the porous starch adsorption core, chitosan cationic hydration composite layer, hydroxypropyl methylcellulose, and sodium alginate. It also includes contributions from the amino groups in chitosan, indicating strong hydrogen bonding in the system; 2920 cm⁻¹ -1The nearby CH stretching vibration peaks correspond to the methylene and methine structures in the polysaccharide backbone, indicating that the porous starch and chitosan backbone are still retained; 1600-1650 cm⁻¹ -1 The nearby absorption peaks can be attributed to the superposition of NH bending vibrations, adsorbed water bending vibrations, and carboxylate-related vibrations in chitosan, combined with the 1550 cm⁻¹ peak. -1 The characteristic NH absorption in the vicinity indicates that the chitosan cationic hydration composite layer has been introduced into the composite particles; 1450-1400 cm⁻¹ -1 The COO- characteristic absorption in the vicinity is related to the carboxylate structures of sodium citrate, sodium alginate, and calcium lactate, indicating that carboxylate-mediated complexation / crosslinking exists in the sodium citrate-assisted sodium phytate-chitosan complex intermediate layer and the calcium-polyanionic crosslinked outer layer; 1250-1000 cm⁻¹ -1 Strong COC, CO, and PO-related absorptions were observed within the range. COC and CO mainly correspond to the polysaccharide backbones of porous starch, chitosan, hydroxypropyl methylcellulose, and sodium alginate. PO and phosphate-related absorptions originated from the phosphate ester / phosphate structure in the sodium phytate molecule, indicating that sodium phytate participated in the formation of a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer; 900-600 cm⁻¹ -1 The weak absorption peaks in the region can be attributed to PO, CO and sugar ring skeleton vibrations, further supporting the coexistence of polysaccharide skeleton, sodium phytate complex structure and calcium ion cross-linking structure in this regulator.
[0051] like Figure 2 As shown, the modified porous starch-chitosan composite sustained-release regulator obtained in Preparation Example 1 has an irregular granular morphology with a relatively rough surface and retains obvious pores and uneven structures. This indicates that after chitosan coating, sodium phytate complexation, and calcium ion crosslinking treatment, the original porous structure of the porous starch is still retained to a certain extent, and a composite coating structure is formed on its surface. The EDS elemental distribution results show that C and O elements are widely distributed in the particle area, N elements mainly come from chitosan and are distributed on the particle surface and near-surface area, Na and P elements correspond to sodium-containing components such as sodium citrate, sodium phytate, and sodium alginate in the system and phytate structure, respectively, and Ca elements have a relatively obvious distribution on the particle surface and near-surface area, indicating that calcium-containing components can be retained in the composite particles. Based on the above SEM morphology and EDS elemental distribution, it can be seen that after stepwise coating, polyelectrolyte complexation and calcium ion crosslinking treatment, Preparation Example 1 formed a composite particle structure composed of porous starch as the base, chitosan, and phosphorus and calcium-containing components. This result is consistent with the composition and preparation process of the modified porous starch-chitosan composite sustained-release regulator described in this invention.
[0052] Comparative Preparation Example 1 The modified porous starch-chitosan composite sustained-release regulator was prepared by referring to the preparation method in Preparation Example 1, except that the porous starch was replaced with an equal mass of ordinary corn starch, and the other raw materials, amounts, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0053] Comparative Preparation Example 2 The modified porous starch-chitosan composite sustained-release regulator was prepared by referring to the preparation method in Preparation Example 1, except that the chitosan was replaced with an equal mass of hydroxypropyl methylcellulose, and the other raw materials, amounts, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0054] Comparative preparation example 3 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that sodium citrate was replaced with an equal mass of sodium chloride, and other raw materials, dosages, steps, temperatures, times, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0055] Comparative preparation example 4 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that sodium phytate was replaced with an equal mass of sodium tripolyphosphate, and other raw materials, dosages, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0056] Comparative preparation example 5 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that the calcium lactate was replaced with an equal mass of calcium chloride, and the other raw materials, dosages, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0057] Comparative preparation example 6 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that sodium alginate was replaced with an equal mass of hydroxypropyl methylcellulose, and other raw materials, amounts, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0058] Comparative preparation example 7 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that the dropping rate of the sodium phytate aqueous solution was replaced from 1.0 mL / min to 5.0 mL / min, and the other raw materials, dosages, steps, temperature, time, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0059] Comparative Preparation Example 8 The modified porous starch-chitosan composite sustained-release regulator was prepared according to the preparation method in Preparation Example 1, except that the crosslinking reaction time in step S4 was replaced from 3.5 h to 0.5 h, and the other raw materials, amounts, steps, temperature, pH, rotation speed, washing, drying and sieving conditions were kept the same as in Preparation Example 1.
[0060] Example 1
[0061] Preparation of a sodium carboxymethyl cellulose sustained-release microsphere: 1. Weight of raw materials: 100 parts sodium carboxymethyl cellulose, 30 parts ibuprofen, 25 parts sodium alginate, 12 parts hydroxypropyl methylcellulose, 15 parts modified porous starch-chitosan composite sustained-release regulator obtained in Preparation Example 1, 6 parts microcrystalline cellulose, 3 parts glycerol, 12 parts calcium chloride, 5 parts sodium tripolyphosphate, 1.5 parts glacial acetic acid, 1.2 parts sodium bicarbonate, 60 parts ethanol, and 620 parts purified water.
[0062] The 2% aqueous solution of sodium carboxymethyl cellulose has a viscosity of 1200-1800 mPa·s, a degree of substitution of 0.9, and a blane content. TM Sodium carboxymethyl cellulose.
[0063] The 2% aqueous solution of hydroxypropyl methylcellulose had a viscosity of 5574 mPa·s and was purchased from Shanghai Maclean Biochemical Technology Co., Ltd.
[0064] Sodium alginate, with a 1% aqueous solution having a viscosity of 21 cps, was purchased from Shanghai Maclean Biochemical Technology Co., Ltd.
[0065] 2. Preparation method: A1. Weigh 380 parts of purified water, heat to 35℃, and add 100 parts of sodium carboxymethyl cellulose, 25 parts of sodium alginate and 12 parts of hydroxypropyl methyl cellulose in sequence under stirring at 700r / min. After the addition is completed, continue stirring for 2 hours to fully hydrate and disperse the polymer components to obtain a composite polymer matrix liquid.
[0066] A2. 30 parts of ibuprofen were premixed with 15 parts of the modified porous starch-chitosan composite sustained-release regulator obtained in Preparation Example 1 for 5 minutes. This mixture was then added to the composite polymer matrix liquid obtained in step A1 and dispersed at 32℃ and 900 r / min for 60 minutes to ensure uniform dispersion of ibuprofen in the composite polymer matrix liquid. Partial adsorption and fixation were achieved through the accessible pores of the porous starch, the cationic hydration composite layer of chitosan, and hydrogen bonds, hydrophobic adsorption, and electrostatic interactions in the polysaccharide network. Unadsorbed ibuprofen was dispersed along with the matrix network formed by sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methylcellulose. Subsequently, 6 parts of microcrystalline cellulose and 3 parts of glycerol were added, and dispersion continued for 15 minutes to ensure that the microcrystalline cellulose, acting as a supporting filler, was uniformly distributed in the composite polymer matrix liquid, resulting in a drug-loaded dispersion.
[0067] A3. Add 1.5 parts of glacial acetic acid to the drug-loaded dispersion obtained in step A2, stir at 500 r / min for 15 min, and adjust the pH of the system to 5.8; then add 1.2 parts of sodium bicarbonate, continue stirring for 25 min, and stabilize the pH of the system at 6.0 to obtain the pre-spherical solution.
[0068] A4. Weigh 240 parts of purified water and 60 parts of ethanol and mix them together. The mass ratio of purified water to ethanol is 4:1. Add 12 parts of calcium chloride and 5 parts of sodium tripolyphosphate. Stir at 25℃ and 500r / min for 30min to completely dissolve the calcium chloride and sodium tripolyphosphate to obtain a composite ion crosslinking liquid. The mass concentration of calcium chloride in the composite ion crosslinking liquid is 3.79%, and the mass concentration of sodium tripolyphosphate is 1.58%.
[0069] A5. After allowing the pre-spherical solution obtained in step A3 to stand for degassing for 20 min, use a 0.60 mm inner diameter dropping needle to drop it into the composite ion crosslinking solution obtained in step A4 at a dropping rate of 1.5 mL / min and a dropping height of 7 cm. During the dropping process, control the composite ion crosslinking solution to be stirred at 350 r / min and solidify and crosslink at 28℃ for 4 h, so that sodium alginate and calcium ions form a calcium ion crosslinking gel structure, and sodium tripolyphosphate forms an ion complex with the chitosan cationic hydration composite layer and other cationic sites in the system. After solidification, filter and collect the spherical product, wash with purified water until the pH of the washing solution is 6.8, and dry at 45℃ for 16 h. After drying, pass through a 20-mesh sieve and be retained by a 30-mesh sieve, collect the sieve fractions with a particle size of 0.60-0.85 mm, and obtain sodium carboxymethyl cellulose sustained-release microspheres.
[0070] Example 2
[0071] The preparation of sodium carboxymethyl cellulose sustained-release microspheres is carried out according to the preparation method of Example 1, except that the mass fraction of the modified porous starch-chitosan composite sustained-release regulator is replaced with 8 parts, and the rest is the same as in Example 1.
[0072] Example 3
[0073] The preparation of sodium carboxymethyl cellulose sustained-release microspheres is carried out according to the preparation method of Example 1, except that the mass fraction of the modified porous starch-chitosan composite sustained-release regulator is replaced with 22 parts, and the rest is the same as in Example 1.
[0074] Comparative Examples 1-8 The preparation of sodium carboxymethyl cellulose sustained-release microspheres is carried out by referring to the preparation method of Example 1, except that the modified porous starch-chitosan composite sustained-release regulator is replaced in turn with the modified porous starch-chitosan composite sustained-release regulator prepared in Comparative Preparation Examples 1-8, and the rest is the same as in Example 1.
[0075] Comparative Example 9 The preparation of sodium carboxymethyl cellulose sustained-release microspheres is carried out according to the preparation method of Example 1, except that the modified porous starch-chitosan is not added, and the rest is the same as in Example 1.
[0076] Performance testing: 1. Determination of Drug Loading and Encapsulation Efficiency: The drug loading and encapsulation efficiency of the sodium carboxymethyl cellulose sustained-release microspheres were determined by high-performance liquid chromatography (HPLC). 100 mg of dried microspheres were accurately weighed and placed in a stoppered centrifuge tube. 25 mL of a methanol-0.1 mol / L sodium hydroxide solution mixture (volume ratio of methanol to 0.1 mol / L sodium hydroxide solution: 90:10) was added. After vortexing for 5 min, ultrasonic extraction was performed for 40 min to fully disrupt the microsphere gel network and ionic cross-linking structure, transferring ibuprofen to the extract. The mixture was then centrifuged at 10000 r / min for 12 min, and the supernatant was collected. The residue was extracted twice more using the same method. The extracts were combined and diluted to a final volume. After filtration through a 0.45 μm microporous membrane, the ibuprofen content was determined by HPLC. The recovery rate of ibuprofen was verified to be 98.0%–102.0%, with a relative standard deviation of no more than 2.0%. The data are shown in Table 1.
[0077] Drug loading (%) = (Mass of active pharmaceutical ingredient measured in the microsphere sample / Dry mass of the microsphere sample) × 100%; Theoretical drug loading (%) = (mass of active pharmaceutical ingredient fed / total mass of pellet solids fed) × 100%; Encapsulation efficiency (%) = (actual drug loading / theoretical drug loading) × 100%.
[0078] 2. In vitro release performance test: The sodium carboxymethyl cellulose sustained-release microspheres obtained in Examples 1-3 and Comparative Examples 1-9 were used. The sample amount equivalent to 30 mg of ibuprofen was accurately weighed based on the measured drug loading obtained by the above-described destructive complete extraction method and placed in a dissolution vessel. First, 900 mL of hydrochloric acid solution with pH 1.2 was added as a simulated gastric juice release medium. The release temperature was controlled at 37±0.5℃, and the impeller speed at 50 r / min for 2 h. Then, the sample was removed and transferred to 900 mL of phosphate buffer with pH 6.8, and the release test was continued at 37±0.5℃ and 50 r / min for 24 h.
[0079] Five mL of the released solution was collected at 0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 16 h, and 24 h. An equal volume of release medium at the same temperature and pH was added immediately after each sampling. The resulting released solution was filtered through a 0.45 μm microporous membrane, and the filtrate was used as the test solution. The ibuprofen content in the test solution was determined by high-performance liquid chromatography (HPLC). The chromatographic conditions were: C18 column, acetonitrile-phosphate buffer (60:40 v / v), flow rate 1.0 mL / min, column temperature 30 °C, detection wavelength 220 nm, and injection volume 20 μL. A standard curve was established using ibuprofen reference solutions of different concentrations, and the ibuprofen concentration in the released solution at each time point was calculated based on the standard curve. This release process evaluates the hydration, desorption, and diffusion behavior of the dried and solidified microspheres in a simulated gastrointestinal medium, and is not equivalent to the dispersion and adsorption process in the slurry during the preparation stage.
[0080] Calculate the cumulative release rate at each time point using the following formula: Cumulative release rate / % = (Ct×V + ΣCi×Vs) / M×100%; In the formula, Ct is the mass concentration of ibuprofen in the release solution at time t, mg / mL; V is the total volume of the release medium, mL; Ci is the mass concentration of ibuprofen in the release solution at the i-th sampling, mg / mL; Vs is the sampling volume each time, mL; M is the actual content of ibuprofen in the test sample, mg, which is determined by converting the measured drug loading obtained by the destructive complete extraction method. The data are shown in Table 1.
[0081] The cumulative release rate in hydrochloric acid solution at pH 1.2 over 2 hours was used as an evaluation index for the initial release performance in the gastric juice stage; the cumulative release rates in phosphate buffer solution at pH 6.8 over 12 hours and 24 hours were used as evaluation indicators for the sustained release performance in the intestinal juice stage. If the sample obtained in the examples has a low cumulative release rate at 2 hours, but maintains a high cumulative release rate at 12 hours and 24 hours, it indicates that the modified porous starch-chitosan composite sustained-release regulator described in this invention can reduce the initial burst release of the active pharmaceutical ingredient and ensure subsequent sustained release.
[0082] 3. Post-release structural integrity test: 0.5000 g of each of the sodium carboxymethyl cellulose sustained-release microspheres obtained in Examples 1-3 and Comparative Examples 1-9 were accurately weighed and added to 100 mL of hydrochloric acid solution with pH 1.2. The mixture was shaken at 37±0.5℃ and 100 r / min for 2 h. Separately, the same mass of the sample was added to 100 mL of phosphate buffer with pH 6.8 and shaken at 37±0.5℃ and 100 r / min for 12 h. After treatment, the samples were collected by filtration through a 100-mesh sieve, and the surface residual release medium was quickly rinsed with a small amount of purified water. The samples were dried to constant weight at 45℃, and the residual sample mass was weighed. The data are shown in Table 1.
[0083] Calculate the structural retention rate using the following formula: Structural retention rate / % = m2 / m0 × 100%; In the formula, m0 is the dry mass of the microspheres before the test, in g; m2 is the residual mass of the microspheres after treatment with the release medium and drying, in g.
[0084] Table 1. Performance test data of the examples and comparative examples
[0085] As shown in Table 1, the drug loading of sodium carboxymethyl cellulose sustained-release microspheres obtained in Examples 1-3 was 12.89-13.74%, the encapsulation efficiency was 90.8-94.0%, the cumulative release rate in pH 1.2 hydrochloric acid solution for 2 hours was 9.5-15.6%, and the cumulative release rate in pH 6.8 phosphate buffer solution for 24 hours was 88.7-93.4%. The structure retention rate remained at a high level after release, indicating that the microspheres can inhibit rapid exudation in the initial stage in acidic conditions and can still achieve continuous release in near-neutral phosphate buffer solution. The reason lies in the fact that sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methyl cellulose form a continuous hydrophilic gel framework, while calcium chloride and sodium tripolyphosphate construct a complex ionic cross-linking network. The porous adsorption core, chitosan cationic composite layer, sodium phytate-sodium citrate complexing intermediate layer, and calcium-polyanionic cross-linking outer layer in the modified porous starch-chitosan composite sustained-release regulator collectively enhance drug fixation, interfacial compatibility, and network barrier effects, thereby regulating water entry, drug desorption, and drug diffusion processes at multiple levels. In contrast, comparative examples, due to weakening pore adsorption, cationic coating, complexation retardation, calcium ion cross-linking outer layer, or cross-linking process conditions, exhibited decreased encapsulation efficiency, increased cumulative release rate in the acidic phase, and reduced post-release structure retention. Comparative example 9, without the addition of the modified porous starch-chitosan composite sustained-release regulator, showed insufficient drug loading fixation and network stability, with the highest release rate and lowest structure retention in the acidic phase. This indicates that the composite sustained-release regulator plays a major role in reducing initial burst release, maintaining microsphere structural integrity, and achieving subsequent sustained release.
[0086] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.
Claims
1. A sodium carboxymethylcellulose sustained release microsphere, characterized by, The microspheres are prepared from the following raw materials in parts by weight: 100 parts sodium carboxymethyl cellulose, 15-45 parts active pharmaceutical ingredient, 15-35 parts sodium alginate, 6-18 parts hydroxypropyl methylcellulose, 8-22 parts modified porous starch-chitosan composite sustained-release regulator, 3-10 parts microcrystalline cellulose, 1-5 parts glycerol, 8-20 parts calcium chloride, 2-8 parts sodium tripolyphosphate, 0.5-3 parts glacial acetic acid, 0.5-3 parts sodium bicarbonate, 40-100 parts ethanol, and 300-650 parts purified water. The modified porous starch-chitosan composite sustained-release regulator is a core-shell-complex network type composite sustained-release regulator composed of a porous starch adsorption core, a chitosan cationic hydration composite layer, a sodium citrate-assisted sodium phytate-chitosan complex intermediate layer, and a calcium-polyanion crosslinked outer layer. The modified porous starch-chitosan composite sustained-release regulator is prepared from the following raw materials in parts by weight: 100 parts porous starch, 25-55 parts chitosan, 6-18 parts sodium citrate, 4-12 parts sodium phytate, 5-16 parts calcium lactate, 2-8 parts hydroxypropyl methylcellulose, 1-5 parts tannic acid, 1-6 parts sodium alginate, 1-6 parts glacial acetic acid, 0.5-3 parts sodium bicarbonate, 120-240 parts ethanol, and 2500-4500 parts purified water. The preparation method of the modified porous starch-chitosan composite sustained-release regulator includes the following steps: S1. Porous starch is added to an ethanol-water solution composed of ethanol and purified water, wherein the mass ratio of ethanol to purified water in the ethanol-water solution is 1:2-1:5, and the solid-liquid ratio of porous starch to ethanol-water solution is controlled to be 1:8-1:
15. The mixture is dispersed at 25-35℃ and 300-600r / min for 20-40min. Sodium citrate and sodium bicarbonate are added to adjust the pH of the system to 6.0-7.
2. The mixture is stirred for 40-90min and then filtered to obtain sodium citrate pre-activated porous starch. S2. Chitosan is added to purified water containing glacial acetic acid, wherein the mass concentration of glacial acetic acid in the purified water is 0.5-2.0%, and dissolved at 35-45℃ and 500-800r / min for 1-3h. Tannic acid and hydroxypropyl methylcellulose are added, and the pH is adjusted to 4.5-5.5 to obtain a chitosan cationic coating solution. S3. Add the sodium citrate pre-activated porous starch obtained in step S1 to the chitosan cationic coating solution obtained in step S2, and control the solid-liquid ratio of sodium citrate pre-activated porous starch to chitosan cationic coating solution to be 1:10-1:
18. Stir for 1.5-4h at 30-45℃ and 400-700r / min. Then, add a 1-5% sodium phytate aqueous solution at a dropping rate of 0.5-2.0mL / min. After the addition is complete, adjust the pH to 5.0-6.2 and continue the reaction for 1-3h to obtain the sodium phytate complex coating complex. S4. Dissolve sodium alginate in purified water to prepare a sodium alginate aqueous solution with a mass concentration of 0.3-1.5%. Add the sodium phytate complex obtained in step S3 to the sodium alginate aqueous solution and disperse it so that sodium alginate is adsorbed on the surface and near-surface area of the complex. Dissolve calcium lactate in purified water to prepare a calcium lactate aqueous solution and add it dropwise to the sodium alginate dispersion system containing the sodium phytate complex at a dropping rate of 0.5-2.0 mL / min. Control the solid-liquid ratio of the sodium phytate complex to the sodium alginate dispersion system to be 1:8-1:
16. Perform a cross-linking reaction at 25-40℃ and 300-600 r / min for 2-5 h to form a calcium-polyanionic cross-linked outer layer. S5. Filter the product obtained in step S4, wash it with purified water until the pH of the filtrate is 6.2-7.0, then wash it 1-3 times with an ethanol aqueous solution with a volume fraction of 50-75%, and vacuum dry it at 35-50℃ for 8-18 hours with a vacuum degree of -0.06MPa to -0.09MPa. After drying, use low-shear grinding to gently depolymerize and pass it through a 100-300 mesh sieve to obtain the modified porous starch-chitosan composite sustained-release regulator.
2. The sodium carboxymethyl cellulose sustained-release microspheres according to claim 1, characterized in that, The degree of substitution of the sodium carboxymethyl cellulose is 0.65-0.95, and the viscosity of a 2% aqueous solution at 25°C is 300-2000 mPa·s. The viscosity of the 1% (w / w) aqueous solution of sodium alginate at 25°C is 10-40 cps. The viscosity of the 2% (w / w) aqueous solution of hydroxypropyl methylcellulose is 2600-5800 mPa·s.
3. The sodium carboxymethyl cellulose sustained-release microspheres according to claim 1, characterized in that, The average particle size of the porous starch is 10-80 μm; The degree of deacetylation of the chitosan is ≥75%.
4. The sodium carboxymethyl cellulose sustained-release microspheres according to claim 1, characterized in that, The modified porous starch-chitosan composite sustained-release regulator exhibited a swelling ratio of 4.0-12.0 times in phosphate buffer solution at pH 6.8 for 6 hours.
5. The sodium carboxymethyl cellulose sustained-release microspheres according to claim 1, characterized in that, The active pharmaceutical ingredient is one of ibuprofen, theophylline, metformin, aspirin, diclofenac sodium, berberine hydrochloride, and acetaminophen.
6. The sodium carboxymethyl cellulose sustained-release microspheres according to claim 1, characterized in that, The cumulative release rate of the sodium carboxymethyl cellulose sustained-release microspheres was 5-30% in hydrochloric acid solution at pH 1.2 for 2 hours, 55-90% in phosphate buffer solution at pH 6.8 for 12 hours, and 80-98% in phosphate buffer solution at pH 6.8 for 24 hours.
7. A method for preparing sodium carboxymethyl cellulose sustained-release microspheres as described in any one of claims 1-6, characterized in that, Includes the following steps: A1. Add sodium carboxymethyl cellulose, sodium alginate, and hydroxypropyl methyl cellulose to purified water and stir for 1-3 hours at 25-45℃ and 500-1000r / min to obtain a composite polymer matrix solution. A2. The active pharmaceutical ingredient is premixed with the modified porous starch-chitosan composite sustained-release regulator and then added to the composite polymer matrix liquid obtained in step A1. The mixture is dispersed at 25-40℃ and 600-1200 r / min for 30-90 min to ensure that the active pharmaceutical ingredient is uniformly dispersed in the composite polymer matrix liquid. Partial immobilization is achieved through the adsorption of the porous starch channels, the chitosan cationic hydration composite layer, and the polysaccharide network. Subsequently, microcrystalline cellulose and glycerol are added and dispersion is continued to obtain the drug-loaded dispersion. A3. Add glacial acetic acid to the drug-loaded dispersion obtained in step A2, adjust the pH to 5.0-6.5, then add sodium bicarbonate, and stir for 10-40 minutes at 300-800 r / min to obtain the pre-spherical solution. A4. Dissolve calcium chloride and sodium tripolyphosphate in a mixture of purified water and ethanol to prepare a composite ion crosslinking solution, wherein the mass concentration of calcium chloride in the composite ion crosslinking solution is 1.5-6.0% and the mass concentration of sodium tripolyphosphate is 0.5-3.0%. A5. After allowing the pre-spherical liquid obtained in step A3 to stand for degassing for 10-30 minutes, use a dropping needle or nozzle with an inner diameter of 0.45-0.80 mm to drop it into the composite ion crosslinking liquid obtained in step A4 at a dropping rate of 0.5-3.0 mL / min and a dropping height of 5-10 cm. During the dropping process, control the composite ion crosslinking liquid to be stirred at 200-500 r / min. Cure and crosslink at 20-35℃ for 1-6 h. Filter and collect the spherical product, wash it with purified water until the pH of the washing solution is 6.2-7.2, and dry it at 35-55℃ for 8-24 h. After drying, sieve to remove particles with a particle size greater than 1.50 mm and less than 0.20 mm to obtain sodium carboxymethyl cellulose sustained-release microspheres.
8. The method for preparing sodium carboxymethyl cellulose sustained-release microspheres according to claim 7, characterized in that, The mass ratio of purified water to ethanol in step A4 is 3:1 to 8:1; When the pre-forming sphere liquid is added to the composite ionic crosslinking liquid in step A5, the volume ratio of the pre-forming sphere liquid to the composite ionic crosslinking liquid is 1:5-1:
15.
9. The use of sodium carboxymethyl cellulose sustained-release microspheres as described in any one of claims 1-6 in the preparation of oral sustained-release drug formulations.
Citation Information
Patent Citations
Crosslinked corn porous starch loaded curcumin composite gel microsphere and preparation method thereof
CN114588129A
Application of macromolecular polysaccharide slow-release carrier in medicinal and edible components and preparation method of macromolecular polysaccharide slow-release carrier
CN121513208A
